N-methyl-4-({4-[({3-methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride | |
---|---|
Trade Name | |
Orphan Indication | Malignant pleural mesothelioma |
USA Market Approval | USA |
USA Designation Date | 2013-07-18 00:00:00 |
Sponsor | Verastem, Inc.;117 Kendrick Street, Suite 500;Needham, Massachusetts, 02494 |